Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kelingyuan Biotechnology
Shanghai, Shanghai, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Kelingyuan Biotechnology is a clinical-stage biopharmaceutical company focused on developing innovative therapies that target cancer metabolism and the tumor microenvironment. The company leverages its proprietary metabolic reprogramming platform to design small molecule inhibitors aimed at disrupting the energy supply and waste removal mechanisms of cancer cells. Its lead candidate, KLY-101, is a dual MCT1/MCT4 inhibitor currently being evaluated in clinical trials for the treatment of advanced solid tumors. Kelingyuan aims to address unmet medical needs in oncology by combining deep biological insights with advanced medicinal chemistry. The company is backed by prominent venture capital firms and maintains research facilities in Shanghai.
- Therapeutic areas
- Oncology
- Modalities
- Small molecule
- Industry
- Biotech
Beyond the preview
Go deeper on Kelingyuan Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kelingyuan Biotechnology.